To further explore the cellular roles of SETD3 in colon cancer, we immunoprecipitated SETD3 from HCT-116 cells followed by mass spectrometry and identified 215 novel interacting proteins showing a significant link to DNA damage response pathways. The gene discussed is SETD3; the disease is malignant colon neoplasm.